Paxman
In this fundamental analysis, analysts Dennis Drevell Smith and Anna-Brita Hunter Nilsson examine Paxman AB, a UK based MedTech company operating a de facto monopoly in mechanical scalp cooling. An equally weighted DCF and relative valuation imply a potential upside of 58%, making Paxman a compelling buy opportunity.
